Trials / Conditions / Staphylococcus Aureus Endocarditis

Staphylococcus Aureus Endocarditis

8 registered clinical trials studyying Staphylococcus Aureus Endocarditis — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia NCT06650488	Todd C. Lee MD MPH FIDSA	Phase 4
Recruiting	Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia NCT06650501	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 4
Recruiting	Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus NCT07253688	Todd C. Lee MD MPH FIDSA	Phase 3
Recruiting	Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia NCT06637332	Todd C. Lee MD MPH FIDSA	Phase 4
Recruiting	Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia NCT04886284	Todd C. Lee MD MPH FIDSA	Phase 2
Terminated	Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase NCT04160468	ContraFect	Phase 3
Withdrawn	Oritavancin for Staphylococcus Aureus Infections in Opioid Users NCT03761953	University of Pennsylvania	Phase 4
Completed	Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment NCT03163446	ContraFect	Phase 2